Shih-Fong Chen
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
- Telomeres, Telomerase, and Senescence
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- Adenosine and Purinergic Signaling 3
- Co-authors
- Daniel L. DexterD L BehrensFrank W. PerrellaJohanna D. StoecklerTerace M. FletcherMiguel SalazarRobert E. ParksJan M. Woynarowski
- Journals
- Biochemical Pharmacology (5 papers)Biochemistry (2 papers)International Journal of Oncology (2 papers)The Journal of Organic Chemistry (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesFranceIndia
In The Last Decade
Shih-Fong Chen
22 papers receiving 699 citations
Peers
Comparison fields: 5 of 82
- Physiology 88
- Infectious Diseases 132
- Molecular Biology 479
- Transplantation 15
- Toxicology 17
Countries citing papers authored by Shih-Fong Chen
This map shows the geographic impact of Shih-Fong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih-Fong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih-Fong Chen more than expected).
Fields of papers citing papers by Shih-Fong Chen
This network shows the impact of papers produced by Shih-Fong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih-Fong Chen. The network helps show where Shih-Fong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shih-Fong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2002 | 7 | |
| 3 | 2002 | 18 | |
| 4 | 2001 | 10 | |
| 5 | 1999 | 61 | |
| 6 | 1999 | 34 | |
| 7 | 1997 | 90 | |
| 8 | 1996 | 57 | |
| 9 | 1994 | 54 | |
| 10 | 1993 | 17 | |
| 11 | Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium. | 1992 | 68 |
| 12 | 1990 | 41 | |
| 13 | 1988 | 12 | |
| 14 | Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis. | 1986 | 128 |
| 15 | Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiation. | 1986 | 33 |
| 16 | 1984 | 17 | |
| 17 | 1982 | 37 | |
| 18 | 1982 | 3 | |
| 19 | 1977 | 3 | |
| 20 | 1976 | 2 |
About Shih-Fong Chen
Shih-Fong Chen is a scholar working on Physiology, Complementary and alternative medicine, Molecular Biology, Infectious Diseases and Molecular Medicine, having authored 22 papers that have together received 727 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (6 papers), Cancer therapeutics and mechanisms (6 papers), HIV/AIDS drug development and treatment (4 papers), Adenosine and Purinergic Signaling (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Synthesis and biological activity (2 papers), DNA Repair Mechanisms (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Physiology (88 citations), Infectious Diseases (132 citations), Molecular Biology (479 citations), Transplantation (15 citations) and Toxicology (17 citations). Shih-Fong Chen has collaborated with scholars based in United States, France and India. Frequent co-authors include Daniel L. Dexter, D L Behrens, Frank W. Perrella, Johanna D. Stoeckler, Terace M. Fletcher, Miguel Salazar, Robert E. Parks, Jan M. Woynarowski, Dean A. Troyer and William G. Chapman. Their work appears in journals such as Biochemical Pharmacology, Biochemistry, International Journal of Oncology, The Journal of Organic Chemistry and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.